Schizophrenia Research

Schizophrenia is a chronic, debilitating mental disorder affecting 1-2% of the global population. Symptoms are split into two types; 'positive' symptoms, including delusions and hallucinations, and 'negative' symptoms, including anhedonia and lack of motivation. Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Several neurobiological alterations in brain structure, physiology and neurochemistry have been documented, along with an ever-increasing list of susceptibility genes.

Schizophrenia Research Products Targets

Products for Schizophrenia Research - Page 67

  1. Cat.No. Product Name Information/Activity
  2. BCC6820 MTPG 169209-66-9 MTPG chemical structure
  3. BCC7513 Ro 64-5229 246852-46-0 Ro 64-5229 chemical structure
  4. BCC7849 BINA Biphenylindanone A (BINA) is a selective human mGluR2 (hmGluR2) potentiator for the treatment of many neurological disorders. BINA chemical structure
  5. BCC7824 CBiPES hydrochloride 856702-40-4 CBiPES hydrochloride chemical structure
  6. BCC7985 LY 2389575 hydrochloride 885104-09-6 LY 2389575 hydrochloride chemical structure
  7. BCC7627 LY 487379 hydrochloride 353229-59-1 LY 487379 hydrochloride chemical structure
  8. BCC6343 ML 289 1382481-79-9 ML 289 chemical structure
  9. BCC6345 ML 337 1443118-44-2 ML 337 chemical structure
  10. BCC6156 MNI 137 946619-21-2 MNI 137 chemical structure
  11. BCC7866 Xanthurenic acid Xanthurenic acid is a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus. Xanthurenic acid chemical structure

Items 661 to 670 of 709 total